Aclarion Inc
NASDAQ:ACON
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Aclarion Inc
NASDAQ:ACON
|
US |
|
Pacific Edge Ltd
NZX:PEB
|
NZ |
|
Ideal Power Inc
NASDAQ:IPWR
|
US |
|
Air T Inc
NASDAQ:AIRT
|
US |
|
Greatview Aseptic Packaging Co Ltd
HKEX:468
|
CN |
|
BKM Industries Ltd
NSE:BKMINDST
|
IN |
|
Zodiac Clothing Company Ltd
NSE:ZODIACLOTH
|
IN |
|
E
|
ezCaretech Co Ltd
KOSDAQ:099750
|
KR |
|
HC SemiTek Corp
SZSE:300323
|
CN |
|
BR Properties SA
BOVESPA:BRPR3
|
BR |
|
A
|
Acen Corp
XPHS:ACEN
|
PH |
Aclarion Inc
Aclarion Inc is a US-based company operating in Health Care Technology industry. The company is headquartered in San Mateo, California. The company went IPO on 2022-04-22. Aclarion, Inc. is a healthcare technology company that employs magnetic resonance spectroscopy (MRS) and artificial intelligence (AI) technology to optimize clinical treatments. The Company’s technology is focused on improving surgical decision making when surgical intervention is being contemplated for patients with low back pain. Its first commercial product, NOCISCAN-LS, utilizes its proprietary biomarkers and algorithms to provide surgeons with information about which intervertebral discs are determined to be consistent with generating pain, and which are not. NOCISCAN is a software as a service (SaaS) platform to leverage MRS to non-invasively help physicians distinguish between painful and nonpainful discs in the spine. The platform used to conduct a NOCISCAN-LS involves NOCISCAN-LS MRS exam protocol, data transfer, and the NOCISCAN-LS post-processor suite. The Company’s NOCISCAN-LS post processor suite is comprised of two software products, such as NOCICALC-LS and NOCIGRAM.
Aclarion Inc is a US-based company operating in Health Care Technology industry. The company is headquartered in San Mateo, California. The company went IPO on 2022-04-22. Aclarion, Inc. is a healthcare technology company that employs magnetic resonance spectroscopy (MRS) and artificial intelligence (AI) technology to optimize clinical treatments. The Company’s technology is focused on improving surgical decision making when surgical intervention is being contemplated for patients with low back pain. Its first commercial product, NOCISCAN-LS, utilizes its proprietary biomarkers and algorithms to provide surgeons with information about which intervertebral discs are determined to be consistent with generating pain, and which are not. NOCISCAN is a software as a service (SaaS) platform to leverage MRS to non-invasively help physicians distinguish between painful and nonpainful discs in the spine. The platform used to conduct a NOCISCAN-LS involves NOCISCAN-LS MRS exam protocol, data transfer, and the NOCISCAN-LS post-processor suite. The Company’s NOCISCAN-LS post processor suite is comprised of two software products, such as NOCICALC-LS and NOCIGRAM.
